sr 48968 has been researched along with ibodutant in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellucci, F; Catalani, C; Cucchi, P; Giolitti, A; Giuliani, S; Meini, S; Santicioli, P | 1 |
Bechi, P; Catalani, C; Giuliani, S; Maggi, CA; Meini, S; Riccadonna, S; Ringressi, MN; Santicioli, P | 1 |
2 other study(ies) available for sr 48968 and ibodutant
Article | Year |
---|---|
Multifaceted approach to determine the antagonist molecular mechanism and interaction of ibodutant ([1-(2-phenyl-1R-[[1-(tetrahydropyran-4-ylmethyl)-piperidin-4-ylmethyl]-carbamoyl]-ethylcarbamoyl)-cyclopentyl]-amide) at the human tachykinin NK2 receptor.
Topics: Animals; Benzamides; Binding, Competitive; Cell Line; Cloning, Molecular; Cricetinae; Cricetulus; Dipeptides; Dose-Response Relationship, Drug; Humans; Kinetics; Models, Molecular; Peptides, Cyclic; Phosphatidylinositols; Piperidines; Protein Binding; Radioligand Assay; Receptors, Neurokinin-2; Thiophenes; Type C Phospholipases | 2009 |
Characterization of ibodutant at NK(2) receptor in human colon.
Topics: Aged; Aged, 80 and over; Benzamides; Binding, Competitive; Colon; Dipeptides; Female; Humans; In Vitro Techniques; Male; Middle Aged; Peptides, Cyclic; Piperidines; Radioligand Assay; Receptors, Neurokinin-2; Thiophenes | 2013 |